Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver
- 9 April 2008
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (12), 2800-2804
- https://doi.org/10.1002/ijc.23433
Abstract
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Little is known about its molecular pathogenesis and the relevance of DNA methylation for disease initiation and progression. Nevertheless, promoter methylation of some genes has been implicated as potential marker for HCC. Thirty‐four HCC, 34 matching non‐malignant, cirrhotic livers and 16 normal livers were analyzed for the methylation status of the genes p16INK4a, GSTP1, MGMT, DAP‐K and APC by quantitative methylation‐specific PCR. DNA promoter methylation frequencies in HCC and matching non‐malignant cirrhotic liver, respectively, were as follows: p16INK4a (76% vs. 24%), GSTP1 (53% vs. 32%), MGMT (6 vs. 12%), DAP‐K (68 vs. 100%) and APC (100 vs. 100%). GSTP1 and/or p16INK4a promoter methylation was observed in 88% of the HCC samples. In normal liver tissue, the p16INK4a, GSTP1 and MGMT promoter were not methylated. DAP‐K was methylated in 31% and APC even in 100% of normal liver samples. Quantitative levels of methylated promoter DNA of all genes were significantly different in the various tissue types except for MGMT. Our results suggest that promoter methylation of tumor‐associated genes is a common event in hepatocarcinogenesis. Significantly, higher levels and frequencies of promoter methylation in HCC were found for p16INK4a and GSTP1 compared to non‐malignant cirrhotic liver. This indicates that these epigenetic events may serve as a good marker for HCC. These data also demonstrate the importance of the quantification of methylated promoter DNA within a given sample and the use of normal tissue as controls. Quantitative analyses of methylated GSTP1 and p16INK4a promoter may serve as a powerful molecular marker in detecting HCC in biopsies.Keywords
This publication has 31 references indexed in Scilit:
- Microarray‐based survey of CpG islands identifies concurrent hyper‐ and hypomethylation patterns in tissues derived from patients with breast cancerGenes, Chromosomes and Cancer, 2006
- Gene Promoter Methylation in Prostate Tumor–Associated Stromal CellsJNCI Journal of the National Cancer Institute, 2006
- Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation ProfilingClinical Cancer Research, 2005
- Inactivation of the DNA repair gene O6‐methylguanine‐DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1‐DNA adducts and p53 mutation in hepatocellular carcinomaInternational Journal of Cancer, 2002
- Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated π-Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma CellsPublished by Elsevier BV ,2002
- Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virusGut, 2001
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban populationHepatology, 1995
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994
- X-chromosome inactivation and cell memoryTrends in Genetics, 1992